Persistent URL of this record https://hdl.handle.net/1887/103103
In Collections
This item can be found in the following collections:
![Odanacatib Anti-Fracture Efficacy and Safety in Postmenopausal Women with Osteoporosis: Results from the Phase III Long-Term Odanacatib Fracture Trial](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
Odanacatib Anti-Fracture Efficacy and Safety in Postmenopausal Women with Osteoporosis: Results from the Phase III Long-Term Odanacatib Fracture Trial
- All authors
- McClung, M.R.; Langdahl, B.; Papapoulos, S.; Saag, K.G.; Adami, S.; Bone, H.G.; Villiers, T. de; Kiel, D.P.; Kung, A.; Kumar, P.; Lim, S.K.; Ling, X.; Lippuner, K.; Mautalen, C.; Nakamura, T.; Reginster, J.Y.; Reid, I.R.; Rodriguez-Portales, J.A.; Roux, C.; Walliser, J.; Watts, N.B.; Zanchetta, J.R.; Zerbini, C.A.F.; Rybak-Feiglin, A.; Cohn, D.; DaSilva, C.A.; Massaad, R.; Santora, A.; Scott, B.B.; Verbruggen, N.; Leung, A.; Lombardi, A.
- Date
- 2014-10-31
- Journal
- Arthritis and Rheumatology
- Volume
- 66
- Pages
- S987 - S987